Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT03350308

Prediction of Risk of Hypotension in Hemodialysis

Conditions: Chronical Kidney Disease, Hypotension, Residual Blood Volume, Hemodialysis

Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 60
Sponsor: University Hospital, Clermont-Ferrand

Location: CHU Clermont-Ferrand Clermont-Ferrand

Summary

The main objective is to establish a statistical predictive model of the risk of intradialytic hypotension during hemodialysis (HD) or hemodiafiltration (HDF) sessions based on the measurement of residual blood volume and excess extracellular hydration. The secondary objective is to study the impact of dysfunction in the mechanisms of compensation for decreased blood volume (heart disease, neuropathy, drugs) on the risk of intradialytic hypotension.

Eligibility Criteria

Inclusion Criteria: * 18 years old minimum patients * Patients with chronic end-stage renal failure * Patients treated with hemodialysis for at least 3 months, 3 times a week (duration of sessions 3 to 5 hours) * Patients with at least 2 episodes of intradialytic hypotension in the last month * Patients without acute events within 3 months prior to inclusion * Patients affiliated with or receiving social security benefits Exclusion Criteria: * Hemoglobin levels outside the limits of measurement (\15g/L) * Patients whose probable survival does not exceed 6 months * Patients with progressive acute pathology * Patient following another research protocol that may influence results * Patients with psychiatric pathology or cognitive impairments that make them unable to give informed consent

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT03350308). StuddyBuddy aggregates publicly available trial information.